Videos

Caetano Sabino, BSc, discusses how antimicrobial photodynamic therapy could be used to complement antimicrobial chemotherapy in order to manage drug-resistant infections.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains how restrictions on commercial automated susceptibility testing can affect patient care.

Snigdha Vallabhaneni, MD, MPH, recommends ways for caretakers to protect themselves from acquiring Candida auris.

Kenneth Mayer, MD, discusses new therapies that may have a positive impact on pre-exposure prophylaxis adherence and treatment.

Arjun Srinivasan, MD, shares how to focus your efforts for infectious disease outbreak investigations.

Benjamin Young, MD, PhD, explains the Fast-Track Cities initiative.

Caetano P. Sabino, BSc, PhD Student, explains if photodynamic therapy a cost-effective treatment option.

Meghan Jeffres, PharmD, explains the importance of discussing cross-reactivity among beta-lactams.

Otto Schwake, PhD, discusses the findings of his team’s study exploring Legionella in car washer fluid.

Arjun Srinivasan, MD, stresses the importance of making outbreak investigations a team effort.

Jason Pogue, PharmD, BCPS-ID, explains the limitations of the current drugs for the treatment of Pseudomonas aeruginosa infections.

Caetano Sabino, BSc, explains how photodynamic therapy can be used to challenge microbial resistance of localized infections.

Conan MacDougall, PharmD, explains what individuals should consider when it comes to adopting interventions in antibiotic stewardship programs.

Otto Schwake, PhD, discusses how he and his team sought to validate their hypothesis regarding climate and Legionella presence in car washer fluid.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains how the role of antimicrobial susceptibility tests can be undermined by delays between approval of new antibiotics and the tests that will optimize their use.

Milena McLaughlin, PharmD, MSc, explains the key points that should be incorporated into institutional plans for dealing with antimicrobial shortages.

Snigdha Vallabhaneni, MD, MPH, discusses the drugs available to treat Candida infections.

Conan MacDougall, PharmD, explains how practitioners can adopt antibiotic stewardship interventions that will be beneficial to their specific practice settings.

Elizabeth Phillips, MD, FRCPC, FRACP, explains different strategies for improving antibiotic allergy management.

Kenneth Mayer, MD, discusses the current challenges of improving pre-exposure prophylaxis delivery and adherence in the United States.

Meghan Jeffres, PharmD, explains what practitioners should keep in mind when prescribing beta-lactams.

Otto Schwake, PhD, explains how likely it is for someone to catch Legionnaire’s disease from windshield washer fluid.

Snigdha Vallabhaneni, MD, MPH, discusses the incidence of Candida auris in the United States.

Conan MacDougall, PharmD, discusses some interventions that have been shown to produce negative behavioral changes for antibiotic stewardship.

Belinda Ostrowsky, MD, MPH, explains how to treat patients who expect to receive an antibiotic, but should not.

Kirk Hevener, PharmD, PhD, explains why narrow-spectrum antibiotics are more beneficial for treating C. difficile.

Milena McLaughlin, PharmD, MSc, explains strategies institutions can take to address antimicrobial shortages.

Jason Gallagher, PharmD, BCPS, FCCP, FIDSA, explains the importance of antimicrobial susceptibility testing for off-label indications.